摘è¦
å…疫力是一个平衡的地ä½ï¼Œå…·æœ‰è¶³å¤Ÿçš„生物防御能力æ¥æ‰¿è®¤å’Œæ‰“击“éžè‡ªæˆ‘â€ï¼Œä»¥åŠæ‰¿è®¤â€œè‡ªæˆ‘â€çš„充分宽容。为了维æŒè¿™ç§å…疫稳æ€ï¼Œéœ€è¦ç»„织良好的T细胞å…疫网络,其部分å–决于替代效应T细胞的良好控制的å‘展,具有ä¸åŒçš„ç»†èƒžå› åè°±ç³»ã€‚æœ€è¿‘çš„ç ”ç©¶æŒ‡å‡ºï¼Œå‘展胎儿T细胞网络是早期生活ä¸ä¸è‰¯å› ç´ çš„éžå¸¸æ•æ„Ÿçš„毒ç†å¦é¶ä½ã€‚æµè¡Œç—…å¦å’Œå®žéªŒç ”究显示,T细胞å‘育毒性与æˆäººå…疫疾病之间å˜åœ¨ç€å¯†åˆ‡çš„关系。考虑到炎症和å…疫疾病已æˆä¸ºå…¨çƒæ—¥ç›Šå¢žé•¿çš„å¥åº·é—®é¢˜ï¼ŒçŽ°åœ¨è¶Šæ¥è¶Šå¤šåœ°å…³æ³¨T细胞的å‘育毒性。我们æ出,ä¸åˆ©å› ç´ å¯èƒ½å¯¹æ—©æœŸç”Ÿå‘½ä¸å…疫系统的关键功能有编程效应,这对于胎儿T细胞å‘育和ä¸åŒT细胞谱系平衡的建立至关é‡è¦ã€‚永久性干扰的胸腺内或外周T细胞å‘育å¯èƒ½å过æ¥å¯¼è‡´åŽæœŸç”Ÿæ´»ä¸çš„å…疫疾病。在本手稿ä¸ï¼Œæˆ‘们回顾了å…疫功能障ç¢å’Œå…疫疾病åŽæœŸçš„ä¸åˆ©å› ç´ å¦‚ä½•å½±å“早期生命的T细胞å‘育,进一æ¥é˜æ˜Žäº†æœºåˆ¶ã€‚这些机制将有助于通过干扰这些途径预防和治疗å…疫疾病æµè¡ŒçŽ‡çš„å¢žåŠ ã€‚
关键è¯: å…疫毒ç†å¦ï¼Œç”Ÿæ®–毒性,T细胞,胸腺细胞,胸腺,å…疫疾病。
Current Drug Targets
Title:Reproductive Toxicity of T Cells in Early Life: Abnormal Immune Development and Postnatal Diseases
Volume: 18 Issue: 10
关键è¯: å…疫毒ç†å¦ï¼Œç”Ÿæ®–毒性,T细胞,胸腺细胞,胸腺,å…疫疾病。
摘è¦: Immunity is a balanced status with adequate biological defenses to recognize and fight “non-selfâ€, as well as adequate tolerance to recognize “selfâ€. To maintain this immune homeostasis, a well-organized T cell immune network is required, which in part depends on the well-controlled development of alternative effector T cells, with different cytokine repertoires. Recent researches have pointed that developing fetal T cells network is a remarkably sensitive toxicological target for adverse factors in early life. Epidemiological and experimental studies showed an inseparable relationship between T cell developmental toxicity and immune diseases in adults. Considering that the inflammatory and immune disorders have become a growing health problem worldwide, increasing attention is now being paid to the T cell developmental toxicity. We propose that adverse factors may have programming effects on the crucial functions of immune system during early life which is critical for fetal T cell development and the establishment of the distinct T cell repertoires balance. The permanently disturbed intrathymic or peripheral T cell development may in turn lead to the immune disorders in later life. In this manuscript, we reviewed how adverse factors affected T cell development in early-life with the consequence of the immune dysfunction and immune diseases, and further elucidate the mechanisms. These mechanisms will be helpful in prevention and treatment of the increased prevalence of immune diseases by interfering those pathways.
Export Options
About this article
Cite this article as:
Reproductive Toxicity of T Cells in Early Life: Abnormal Immune Development and Postnatal Diseases, Current Drug Targets 2017; 18 (10) . https://dx.doi.org/10.2174/1389450117666161124145641
DOI https://dx.doi.org/10.2174/1389450117666161124145641 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Potencial Theranostic Agent for EGF-R Expression Tumors: 177Lu- DOTA-Nimotuzumab
Current Radiopharmaceuticals The Adipose Tissue as a Source of Vasoactive Factors
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Ghrelin: A Molecular Target for Weight Regulation, Glucose and Lipid Metabolism
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Emerging Role of microRNA in Stroke
Current Topics in Medicinal Chemistry The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer
Current Drug Targets Kinase Inhibitor Conjugates
Current Pharmaceutical Design Contribution of Latin American Countries to Cancer Research and Patent Generation: Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Cerebral Aneurysm as an Exacerbating Factor in Stroke Pathology and a Therapeutic Target for Neuroprotection
Current Pharmaceutical Design Serum Biochemical Markers of Brain Injury
Mini-Reviews in Medicinal Chemistry Role of Netrin-1 Beyond the Brain: From Biomarker of Tissue Injury to Therapy for Inflammatory Diseases
Recent Patents on Biomarkers Synthesis, Biological Evaluation and Molecular Dynamics Simulation Studies of Novel Diphenyl Ethers
Medicinal Chemistry Id-1B, an Alternatively Spliced Isoform of the Inhibitor of Differentiation-1, Impairs Cancer Cell Malignancy Through Inhibition of Proliferation and Angiogenesis
Current Molecular Medicine Hypoxia-Inducible Factor: A Potential Therapeutic Target for Rheumatoid Arthritis
Current Drug Targets Magnetic Nanoparticles for MRI of Brain Tumors
Current Pharmaceutical Biotechnology Human Complex Trait Genetics: Lifting the Lid of the Genomics Toolbox - from Pathways to Prediction
Current Genomics Anticancer Activities of New N-hetaryl-2-cyanoacetamide Derivatives Incorporating 4,5,6,7-Tetrahydrobenzo[b]thiophene Moiety
Anti-Cancer Agents in Medicinal Chemistry Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor
Medicinal Chemistry The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
Current Clinical Pharmacology Neuropilin and Neuropilin Associated Molecules as New Molecular Targets in Pancreatic Adenocarcinoma
Anti-Cancer Agents in Medicinal Chemistry Viral-Mediated Gene Transfer for Cancer Treatment
Current Pharmaceutical Biotechnology